EFSA Journal (Oct 2023)

Updated conclusion on the peer review of the pesticide risk assessment of the active substance mecoprop‐P

  • European Food Safety Authority (EFSA),
  • Fernando Alvarez,
  • Maria Arena,
  • Domenica Auteri,
  • Marco Binaglia,
  • Anna Federica Castoldi,
  • Arianna Chiusolo,
  • Angelo Colagiorgi,
  • Mathilde Colas,
  • Federica Crivellente,
  • Chloe De Lentdecker,
  • Isabella De Magistris,
  • Mark Egsmose,
  • Gabriella Fait,
  • Franco Ferilli,
  • Varvara Gouliarmou,
  • Laia Herrero Nogareda,
  • Alessio Ippolito,
  • Frederique Istace,
  • Samira Jarrah,
  • Dimitra Kardassi,
  • Aude Kienzler,
  • Anna Lanzoni,
  • Roberto Lava,
  • Renata Leuschner,
  • Alberto Linguadoca,
  • Christopher Lythgo,
  • Oriol Magrans,
  • Iris Mangas,
  • Ileana Miron,
  • Tunde Molnar,
  • Laura Padovani,
  • Martina Panzarea,
  • Juan Manuel Parra Morte,
  • Simone Rizzuto,
  • Rositsa Serafimova,
  • Rachel Sharp,
  • Csaba Szentes,
  • Andrea Terron,
  • Anne Theobald,
  • Manuela Tiramani,
  • Giorgia Vianello,
  • Laura Villamar‐Bouza

DOI
https://doi.org/10.2903/j.efsa.2023.8344
Journal volume & issue
Vol. 21, no. 10
pp. n/a – n/a

Abstract

Read online

Abstract The conclusions of the European Food Safety Authority (EFSA) following the peer review of the initial risk assessments carried out by the initial competent authorities of the rapporteur Member State, the United Kingdom, and co‐rapporteur Member State, Ireland, for the pesticide active substance mecoprop‐P are reported. Due to the UK leaving the EU, the renewal of approval dossier on mecoprop‐P was reallocated to Ireland, as RMS. The context of the peer review was that required by Commission Implementing Regulation (EU) No 844/2012. The conclusions were reached on the basis of the evaluation of the representative uses of mecoprop‐P as a herbicide on winter and spring wheat (including durum and spelt), barley, rye, oats and triticale. The conclusions were updated following the request from the European Commission to review the risk assessment as regards non‐dietary exposure and the endocrine‐disrupting properties of mecoprop‐P. The reliable end points, appropriate for use in regulatory risk assessment are presented. Missing information identified as being required by the regulatory framework is listed. Concerns are reported where identified.

Keywords